A Test of Behavioral Intervention for Women at High Risk for HIV Infection
|ClinicalTrials.gov Identifier: NCT00006440|
Recruitment Status : Completed
First Posted : August 31, 2001
Last Update Posted : October 31, 2016
The purpose of this study is to find out if it is possible to conduct a group counseling program for women at risk for HIV infection.
Women have been the fastest-growing group with new AIDS diagnoses. The need for ways to reduce HIV infection in women is urgent. It is important to reduce the risk of HIV infection through sexual contact, but it is also important to address drug use. Group counseling may be an effective method.
|Condition or disease|
Women have constituted the fastest-growing group of persons with new AIDS diagnoses for several years. The need to develop and evaluate interventions to reduce the incidence of HIV infection among women is urgent. The behavioral intervention method tested in this study integrates elements from diverse theories and empirical evidence for women to feel empowered to use methods of protection against disease. Although the overall objective of the study intervention is to reduce the risk of HIV infection through sexual contact, the intervention must also address drug usage among women.
Women are randomized in a 1 to 1 ratio to either the intervention or control condition. The Intervention Group participates in 4 group sessions over the course of 1 month and then in an additional reunion session approximately 1 month after the 4th group session. Sessions are 2.5 hours long and include 6 to 10 participants. The sessions involve talking about HIV, ways to avoid HIV, and ways women can support each other. All participants complete a short-term assessment visit 1 week after the 4th group intervention session. The Control Group does not participate in group sessions. All participants are paid for their time and effort.
|Study Type :||Observational|
|Estimated Enrollment :||180 participants|
|Official Title:||Feasibility Study of a Behavioral Intervention for Women at Persistent High Risk for HIV Infection|
|Study Start Date :||March 2000|
|Primary Completion Date :||May 2008|
|Study Completion Date :||May 2008|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00006440
|United States, Massachusetts|
|Cambridge, Massachusetts, United States, 02138|
|Study Chair:||Erica Gollub|